— Know what they know.
Not Investment Advice

KIDS NASDAQ

OrthoPediatrics Corp.
1W: +1.4% 1M: +5.5% 3M: +19.2% YTD: +35.6% 1Y: +39.9% 3Y: -7.1% 5Y: -62.5%
$23.82
-0.20 (-0.83%)
 
Weekly Expected Move ±5.4%
$22 $23 $24 $26 $27
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 68 · $621.9M mcap · 18M float · 1.16% daily turnover · Short 43% of daily vol
Credit Risk of going bust: lower than 64% of companies Debt: 12.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.30 (down 99%), OrthoPediatrics Corp. would be worth roughly what it owes.
Total debt $91.6M against a stock market value of $627.2M.
Distance to default 6.78 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $45.9M (short-term plus half of long-term), stock volatility 41.8%; Altman Z 2.23. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
0.60
Bullish
2 bullish 1 neutral 0 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (42)
OrthoPediatrics (KIDS) Q3 2026 Earnings Call Transcript
Bullish MotleyFool · 56m ago · 0.90
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
Bullish Zacks · 2h ago · 0.90
OrthoPediatrics Non-GAAP EPS of -$0.23 misses by $0.02, revenue of $72.7M beats by $4.2M
SeekingAlpha · 3h ago · 0.00
OrthoPediatrics Corp. (NASDAQ:KIDS) Stock Has Average Target Price of $26.50
Bullish DefenseWorld · 1w ago · 0.90
Jennifer Pritzker Sells 302,369 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock
Bearish DefenseWorld · 6w ago · -0.90
Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Director Sells $6,352,772.69 in Stock
Bearish DefenseWorld · 6w ago · -0.90
Squadron Capital Llc Sells 302,369 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock
Bearish DefenseWorld · 6w ago · -0.90
OrthoPediatrics (KIDS) Q2 2026 Earnings Call Transcript
Bullish MotleyFool · 11w ago · 0.90
OrthoPediatrics Corp. Q2 2026 Earnings Call Summary
Yahoo-TopStories · 11w ago · 0.00
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates
Bullish Zacks · 12w ago · 0.90
OrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
GlobeNewsWire-FDA · 22w ago · 0.00
OrthoPediatrics raises 2026 revenue outlook to $263M-$267M while targeting free cash flow breakeven
Bullish SeekingAlpha · 25w ago · 0.90
OrthoPediatrics (KIDS) Q1 2026 Earnings Transcript
MotleyFool · 25w ago · 0.00
OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks · 25w ago · 0.00
OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates
Bearish Zacks · 25w ago · -0.90
OrthoPediatrics Q1 2026 Earnings Call: Complete Transcript
Benzinga-News · 25w ago · 0.00
OrthoPediatrics GAAP EPS of -$0.45 beats by $0.04, revenue of $59.4M beats by $1.06M
Bullish SeekingAlpha · 25w ago · 0.90
OrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial Guidance
Bullish GlobeNewsWire-EarningsResults · 25w ago · 0.90
Earnings Scheduled For April 30, 2026
Benzinga-Earnings · 25w ago · 0.00
Analysts Set OrthoPediatrics Corp. (NASDAQ:KIDS) Price Target at $24.67
Bullish DefenseWorld · 26w ago · 0.90
OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference
Benzinga-News · 30w ago · 0.00
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of “Moderate Buy” by Brokerages
Bullish DefenseWorld · 30w ago · 0.90
Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know
Bullish Zacks · 31w ago · 0.90
OrthoPediatrics Corp. (NASDAQ:KIDS) Receives $24.67 Average Price Target from Brokerages
Bullish DefenseWorld · 33w ago · 0.90
OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?
Bullish Zacks · 34w ago · 0.90
Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?
Bullish Zacks · 34w ago · 0.90
OrthoPediatrics (KIDS) Q4 2025 Earnings Transcript
MotleyFool · 34w ago · 0.00
OrthoPediatrics to Participate in Upcoming Conferences
GlobeNewsWire · 34w ago · 0.00
OrthoPediatrics reiterates $262M–$266M 2026 revenue target as product innovation super cycle accelerates
Bullish SeekingAlpha · 34w ago · 0.90
OrthoPediatrics GAAP EPS of -$0.43 misses by $0.09, revenue of $61.6M beats by $0.33M
Bearish SeekingAlpha · 34w ago · -0.90
OrthoPediatrics Corp. (KIDS) Q4 2025 Earnings Call Transcript
SeekingAlpha · 34w ago · 0.00
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks · 34w ago · 0.00
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
Bullish Zacks · 34w ago · 0.90
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
Bearish GlobeNewsWire · 34w ago · -0.90
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewsWire · 36w ago · 0.00
New York State Common Retirement Fund Has $3.54 Million Position in OrthoPediatrics Corp. $KIDS
Bearish DefenseWorld · 37w ago · -0.90
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of “Moderate Buy” by Brokerages
Bullish DefenseWorld · 37w ago · 0.90
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
Bullish GlobeNewsWire · 38w ago · 0.90
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?
Bullish Zacks · 41w ago · 0.90
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
Bullish GlobeNewsWire · 41w ago · 0.90
Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet
Bullish Zacks · 47w ago · 0.90
OrthoPediatrics (NASDAQ:KIDS) vs. Precision Optics (NASDAQ:POCI) Financial Survey
DefenseWorld · 48w ago · 0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms